Project Number 5R44AG062021-03 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Scale-up and Synthesis of a Tau Oligomer Inhibitor to initiate IND enabling studies for AD and ADRD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator MOE, JAMES G Principal Investigator First Name JAMES Principal Investigator Last Name MOE Awardee Organization OLIGOMERIX, INC Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-18-187: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $999,937 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
